Oppenheimer Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$517K Sell
2,002
-6,937
-78% -$1.79M 0.01% 874
2025
Q1
$2M Sell
8,939
-741
-8% -$166K 0.02% 519
2024
Q4
$2.21M Sell
9,680
-309
-3% -$70.7K 0.03% 499
2024
Q3
$2.44M Sell
9,989
-188
-2% -$45.9K 0.03% 488
2024
Q2
$1.95M Buy
10,177
+674
+7% +$129K 0.02% 528
2024
Q1
$1.88M Sell
9,503
-572
-6% -$113K 0.03% 507
2023
Q4
$1.73M Buy
10,075
+537
+6% +$92.4K 0.02% 557
2023
Q3
$1.41M Sell
9,538
-88
-0.9% -$13K 0.02% 597
2023
Q2
$2.1M Sell
9,626
-107
-1% -$23.4K 0.03% 497
2023
Q1
$2.13M Sell
9,733
-664
-6% -$145K 0.03% 472
2022
Q4
$2.16M Sell
10,397
-67
-0.6% -$13.9K 0.03% 451
2022
Q3
$2.28M Sell
10,464
-627
-6% -$137K 0.04% 417
2022
Q2
$2.33M Sell
11,091
-17
-0.2% -$3.56K 0.04% 426
2022
Q1
$2.69M Sell
11,108
-252
-2% -$61.1K 0.04% 442
2021
Q4
$2.96M Buy
11,360
+92
+0.8% +$24K 0.04% 435
2021
Q3
$2.97M Sell
11,268
-378
-3% -$99.6K 0.04% 408
2021
Q2
$2.87M Buy
11,646
+129
+1% +$31.8K 0.04% 426
2021
Q1
$2.24M Buy
11,517
+464
+4% +$90K 0.03% 479
2020
Q4
$2.35M Sell
11,053
-281
-2% -$59.7K 0.04% 436
2020
Q3
$1.94M Sell
11,334
-169
-1% -$29K 0.04% 435
2020
Q2
$2.21M Sell
11,503
-1,946
-14% -$374K 0.05% 379
2020
Q1
$1.98M Sell
13,449
-412
-3% -$60.7K 0.05% 353
2019
Q4
$2.15M Sell
13,861
-169
-1% -$26.2K 0.05% 398
2019
Q3
$1.9M Sell
14,030
-466
-3% -$63K 0.04% 421
2019
Q2
$1.77M Buy
14,496
+187
+1% +$22.8K 0.04% 441
2019
Q1
$1.49M Buy
14,309
+60
+0.4% +$6.24K 0.03% 478
2018
Q4
$1.62M Sell
14,249
-527
-4% -$60K 0.04% 413
2018
Q3
$1.71M Sell
14,776
-345
-2% -$39.8K 0.04% 458
2018
Q2
$1.57M Sell
15,121
-1,123
-7% -$116K 0.04% 459
2018
Q1
$1.6M Sell
16,244
-1,647
-9% -$162K 0.04% 444
2017
Q4
$1.38M Hold
17,891
0.04% 498
2017
Q3
$1.38M Buy
17,891
+85
+0.5% +$6.54K 0.04% 500
2017
Q2
$1.39M Sell
17,806
-312
-2% -$24.3K 0.04% 475
2017
Q1
$1.3M Buy
+18,118
New +$1.3M 0.04% 489